|
BRD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.135600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.096000E-01 |
| Normal-vs-Stage2 |
5.833800E-01 |
| Normal-vs-Stage3 |
6.200400E-03 |
| Normal-vs-Stage4 |
2.376300E-03 |
| Stage1-vs-Stage2 |
2.053600E-01 |
| Stage1-vs-Stage3 |
1.375430E-04 |
| Stage1-vs-Stage4 |
2.1360999999942E-05 |
| Stage2-vs-Stage3 |
1.470240E-01 |
| Stage2-vs-Stage4 |
9.208000E-02 |
| Stage3-vs-Stage4 |
6.271000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.596820E-01 |
| Normal-vs-AfricanAmerican |
5.360400E-01 |
| Normal-vs-Asian |
8.788400E-02 |
| Caucasian-vs-AfricanAmerican |
9.635600E-02 |
| Caucasian-vs-Asian |
9.661600E-02 |
| AfricanAmerican-vs-Asian |
4.205200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.095900E-02 |
| Normal-vs-Female |
2.531200E-01 |
| Male-vs-Female |
2.591800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.379200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.053600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.354770E-01 |
| Normal-vs-Age(81-100Yrs) |
1.454950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.528800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.370200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.663600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.860100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.797800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.518600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.37459999943945E-08 |
| Normal-vs-Grade 2 |
2.329400E-01 |
| Normal-vs-Grade 3 |
1.277990E-02 |
| Normal-vs-Grade 4 |
5.52309999999334E-05 |
| Grade 1-vs-Grade 2 |
1.769970E-04 |
| Grade 1-vs-Grade 3 |
1.18920000513612E-08 |
| Grade 1-vs-Grade 4 |
7.77260478201924E-11 |
| Grade 2-vs-Grade 3 |
5.71739999999377E-05 |
| Grade 2-vs-Grade 4 |
5.85370000250052E-08 |
| Grade 3-vs-Grade 4 |
2.939600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.219500E-02 |
| Normal-vs-ccB subtype |
1.000980E-03 |
| ccA subtype-vs-ccB subtype |
3.89660004262993E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.967800E-01 |
| Normal-vs-N1 |
1.839690E-02 |
| N0-vs-N1 |
1.671790E-01 |
|
|
